Coronaviruses and other novel antiviral targets
Author(s)
Bibliographic Information
Coronaviruses and other novel antiviral targets
（Annual reports in medicinal chemistry / sponsored by the Division of Medicinal Chemistry of the American Chemical Society ; editor-in-chief: Cornelius K. Cain, v. 57）
Academic Press, 2021
- : hbk
Available at / 1 libraries
-
No Libraries matched.
- Remove all filters.
Note
Includes references
Description and Table of Contents
Description
Annual Reports in Medicinal Chemistry, Volume 57 in this long-running series, highlights new advances in the field with this new volume presenting interesting chapters on the Mechanism of action of the broadly acting antiviral drug remdesivir, Improving properties of the nucleobase analogue T-706 as a potential anti-SARS-CoV-2 and anti-influenza compound, Antivirals for RNA virus infections Anno 2020-2021, Broad spectrum antiviral fleximer nucleosides, SARS-CoV-2 main protease inhibitors, The search for antivirals to treat alphavirus infections, Inhibitors of Ebola Virus targeting Innate immune evasion, Uracil derivatives as non-nucleoside inhibitors of viral infections, and more.
Table of Contents
1. Improving properties of the nucleobase analogs T-705/T-1105 as potential antivirals
2. Anno 2021: Which antivirals for the coming decade?
3. Broad spectrum antiviral fleximer nucleosides
4. The search for antivirals to treat alphavirus infections
5. Inhibitors of Ebola Virus targeting Innate immune evasion
6. Uracil derivatives as non-nucleoside inhibitors of viral infections
by "Nielsen BookData"